a. Overview of Celiac Medical Research Study
Our current celiac disease medical research study is a 12-week outpatient study which assesses the efficacy and safety of an oral pill used for the treatment of persistent abdominal symptoms in adult celiac disease patients. There are 3 required clinic visits.
What is Celiac Disease?
Celiac disease is an immune reaction to eating gluten, a protein found in wheat, barley and rye.
If you have celiac disease, eating gluten triggers an immune response in your small intestine. Over time, this reaction damages your small intestine’s lining and prevents it from absorbing some nutrients (malabsorption). The intestinal damage often causes diarrhea, fatigue, weight loss, bloating and anemia, and can lead to serious complications.
In children, malabsorption can affect growth and development, besides causing the symptoms seen in adults.
Currently there is no cure for celiac disease — but for most people, following a strict gluten-free diet can help manage symptoms and promote intestinal healing.
Celiac Disease Medical Research Study Eligibility
You may be eligible to take part in the study if you:
- Subject has a diagnosis of celiac disease for ≥ 12 months before study entry as confirmed by medical record
- Are male and female and at least 18 years of age
- Compensated for time and travel up to $348
If you have been diagnosed with Celiac Disease, contact us today to learn more about our current study opportunities for this diagnosis.
Signup online at (insert link) or email our Patient Recruitment Specialist, Tyrone Belton at email@example.com. You can also call us toll free at 1.888.574.INVO or text us at 803.291.4972.